Microsoft unveiled an AI research system for biological discovery called Quine
The new system connects scientific literature and experimental tools to help researchers predict drug responses in complex cancer cell states.
Microsoft Research introduced Quine, a specialized platform designed to navigate the complex interactions within biological systems. Rather than focusing on a single task, the system integrates data across various scales, such as gene sequences, protein structures, and cellular states.
By connecting literature, lab tools, and computational models, Quine allows scientists to simulate biological changes. The system predicts how a cell might behave if it is treated with specific chemical compounds.
Our north star is a future in which scientists, models, and experiments operate in a continuously accelerating loop.
In a recent collaboration with the Broad Institute of MIT and Harvard, researchers used the platform to study pancreatic cancer. They identified potential drug candidates that could shift tumor cells into less harmful states.
This computational approach significantly narrowed down the search space for effective treatments. The team managed to prioritize promising candidates for lab testing over a single weekend, potentially saving months of manual research.
To encourage further development, Microsoft launched a fellowship program. This initiative provides scientists with access to the system to test hypotheses and offer feedback on its performance.
Despite these advancements, the technology remains in an experimental stage. Quine is not intended for clinical use, and its outputs must be validated by scientists and wet-lab experiments. The system does not perfectly map all biological complexities, and it is currently limited to specific research collaborations.
Source: Microsoft Research Blog